Business / Finance

RSS

BioSpecifics reports net income of $2.7 million for fourth quarter 2015

BioSpecifics Technologies Corp., a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product collagenase clostridium histolyticum, or CCH, marketed as XIAFLEX in the U.S. and Xiapex in Europe, today announced its financial results for the fourth quarter and full year ended December 31, 2015 and provided a corporate update.

14 Mar 2016

Eclipse Aesthetics partners with Skincential Sciences to distribute Clearista product line

Eclipse Aesthetics, LLC has formed a partnership with Skincential Sciences, a medical diagnostics company in southern California. Eclipse will serve as the exclusive distributor for ClearistaPRO, specially formulated products to safely and effectively remove biomarkers from tissue.

13 Mar 2016

BioLineRx announces year end 2015 financial results, provides operational update

BioLineRx Ltd., a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, today reported its financial results for the year ended December 31, 2015.

10 Mar 2016

Universal Biosensors agrees to modify collaboration arrangements with Siemens Healthcare Diagnostics

Universal Biosensors announced today that it has agreed amendments to its arrangements with Siemens Healthcare Diagnostics Inc. The parties have agreed to shift the focus of their joint product development activities, provide prepayment of milestones to UBI and improved strip pricing to support Siemens’ entry into the point-of-care PT-INR testing market.

10 Mar 2016

Merck reports record results for 2015

Merck, a leading science and technology company, reported record results for 2015, emerging stronger from the transformation process that started in 2007. Net sales and EBITDA pre exceptionals were higher than ever before in Merck’s history of nearly 350 years.

From Merck 10 Mar 2016

Quantum Plastics acquires wheelchair stabilizing device company, Transfer Solutions

Quantum Plastics, LLC (Quantum) is expanding its product line with the acquisition of the popular wheelchair stabilizing device company, Transfer Solutions.

10 Mar 2016

Ethicon agrees to acquire NeuWave Medical

Ethicon, a medical device company of the Johnson & Johnson family of companies, today announced a definitive agreement to acquire NeuWave Medical, Inc., a privately held medical device company that manufactures and markets minimally invasive soft tissue microwave ablation systems.

8 Mar 2016

New co-marketing deal to make AMRA Profiler protocol available on future GE Healthcare MRI scanners

AMRA has announced at the European Congress of Radiology in Vienna, Austria, that it has entered into a new co-marketing agreement with GE Healthcare, a leading provider of MRI systems.

4 Mar 2016

IRIDEX reports revenues of $12.1 million for fourth quarter 2015

IRIDEX Corporation today reported financial results for the fourth quarter and year ended January 2, 2016.

4 Mar 2016

CAMH, Impel NeuroPharma partner to advance novel treatment to alleviate depression

The Centre for Addiction and Mental Health and Impel NeuroPharma have signed a licensing agreement to advance a new neuropeptide-based therapeutic approach shown to be effective in treating depression.

1 Mar 2016

Teleradiology Specialists reports record growth in January

Teleradiology Specialists is positioned for explosive volume and market share growth in 2016 after completing a record number of reads in January.

27 Feb 2016

eviCore healthcare acquires Boston-based QPID Health

eviCore healthcare, a company committed to enabling better outcomes for patients, payers and providers through advanced medical benefits management, today announced that it has acquired Boston-based QPID Health.

27 Feb 2016

China Biologic's total sales increase by 22.6% in RMB terms to $68.3 million in Q4 2015

China Biologic Products, Inc., a leading fully integrated plasma-based biopharmaceutical company in China, today announced its financial results for the fourth quarter and fiscal year of 2015.

26 Feb 2016

Insulet partners with Mode AGC to develop OmniPod Artificial Pancreas system

Insulet Corporation, the leader in tubeless insulin pump technology with its OmniPod Insulin Management System (OmniPod System), today announced a license agreement and partnership with Mode AGC (Automated Glucose Control LLC), to develop and incorporate the advanced artificial pancreas algorithm created by renowned researchers Francis Doyle PhD, Eyal Dassau PhD, and Howard Zisser MD.

25 Feb 2016

PolyPid closes $22 million private equity financing

PolyPid Ltd., an emerging clinical-stage specialty pharmaceutical company, focused primarily on the development of post-surgical anti-infection pipeline, announced today that it closed a $22 million private equity financing.

24 Feb 2016

Caribou Biosciences grants IDT worldwide rights to commercialize CRISPR-Cas9 reagents

Caribou Biosciences, Inc., a developer of CRISPR technologies for precision cell engineering, and Integrated DNA Technologies, Inc., a producer of custom synthetic oligonucleotide-based technologies for genomics applications, have entered into a non-exclusive license agreement under which Caribou has granted IDT worldwide rights to commercialize CRISPR-Cas9 reagents under Caribou’s intellectual property.

24 Feb 2016

New study shows beneficial effects of fish consumption during pregnancy

A new study supports the theory that the detrimental effects of low-level exposure to mercury may be outweighed by the beneficial effects of fish consumption.

24 Feb 2016

WebMD Health reports record revenue, earnings for fourth quarter and full year 2015

WebMD Health Corp., the leading source of health information, today announced fourth quarter and full year financial results for 2015.

24 Feb 2016

Diversigen, Baylor Miraca to provide customers access to targeted genomics and metabolomics services

Diversigen, Inc., the leading provider of comprehensive microbiome analysis services, today announced a strategic partnership with Baylor Miraca Genetics Laboratories, a global leader in genetic testing, to provide their customers access to a broad range of targeted genomics and metabolomics services.

23 Feb 2016

Regulus reports net loss of $7.2 million for fourth quarter 2015

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today reported financial results for the fourth quarter and full-year ended December 31, 2015 and provided a summary of recent corporate highlights.

23 Feb 2016

Business / Finance

BioSpecifics reports net income of $2.7 million for fourth quarter 2015

Eclipse Aesthetics partners with Skincential Sciences to distribute Clearista product line

BioLineRx announces year end 2015 financial results, provides operational update

Universal Biosensors agrees to modify collaboration arrangements with Siemens Healthcare Diagnostics

Merck reports record results for 2015

Quantum Plastics acquires wheelchair stabilizing device company, Transfer Solutions

Ethicon agrees to acquire NeuWave Medical

New co-marketing deal to make AMRA Profiler protocol available on future GE Healthcare MRI scanners

IRIDEX reports revenues of $12.1 million for fourth quarter 2015

CAMH, Impel NeuroPharma partner to advance novel treatment to alleviate depression

Teleradiology Specialists reports record growth in January

eviCore healthcare acquires Boston-based QPID Health

China Biologic's total sales increase by 22.6% in RMB terms to $68.3 million in Q4 2015

Insulet partners with Mode AGC to develop OmniPod Artificial Pancreas system

PolyPid closes $22 million private equity financing

Caribou Biosciences grants IDT worldwide rights to commercialize CRISPR-Cas9 reagents

New study shows beneficial effects of fish consumption during pregnancy

WebMD Health reports record revenue, earnings for fourth quarter and full year 2015

Diversigen, Baylor Miraca to provide customers access to targeted genomics and metabolomics services

Regulus reports net loss of $7.2 million for fourth quarter 2015

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Latest News